AlphaYouCG
Insider buying
Column Group Iv Gp, Lp bought $1M of Eikon Therapeutics, Inc. (EIKN) stock
Column Group Iv Gp, Lp, 10% owner of Eikon Therapeutics, Inc. (EIKN), bought 89,200 shares of EIKN stock worth $1M, per an SEC Form 4 filed Sep 8, 2026.
It was an open-market purchase.
The trade happened on Sep 3, 2026, 5 days before it was made public.
EIKN has moved -18.1% since the trade date, from $10.96 to $8.98 (Sep 22, 2026 close).
- Traded
- Sep 3, 2026
- Disclosed
- Sep 8, 2026
- Filing delay
- 5 days
- Price since
- -18.1%
- Role
- 10% owner
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.